Biosynthesis of a steroid metabolite by an engineered Rhodococcus erythropolis strain expressing a mutant cytochrome P450 BM3 enzyme
Biosynthesis of a steroid metabolite by an engineered Rhodococcus erythropolis strain expressing a mutant cytochrome P450 BM3 enzyme
复制标题
DOI:
10.1007/s00253-014-6281-7
复制
发表时间:
2015-06
影响因子:
5
通讯作者:
H. Venkataraman;E. T. Poele;Kamila Z. Rosłoniec;N. Vermeulen;J. Commandeur;R. Geize;L. Dijkhuizen
中科院分区:
文献类型:
--
作者:
H. Venkataraman;E. T. Poele;Kamila Z. Rosłoniec;N. Vermeulen;J. Commandeur;R. Geize;L. Dijkhuizen
In the present study, the use ofRhodococcus erythropolismutant strain RG9 expressing the cytochrome P450 BM3 mutant M02 enzyme has been evaluated for whole-cell biotransformation of a 17-ketosteroid, norandrostenedione, as a model substrate. Purified P450 BM3 mutant M02 enzyme hydroxylated the steroid with >95 % regioselectivity to form 16-β-OH norandrostenedione, as confirmed by NMR analysis. Whole cells ofR. erythropolisRG9 expressing P450 BM3 M02 enzyme also converted norandrostenedione into the 16-β-hydroxylated product, resulting in the formation of about 0.35 g/L. Whole cells of strain RG9 itself did not convert norandrostenedione, indicating that metabolite formation is P450 BM3 M02 enzyme mediated. This study shows thatR. erythropolisis a novel and interesting host for the heterologous expression of highly selective and active P450 BM3 M02 enzyme variants able to perform steroid bioconversions.